| __timestamp | Ascendis Pharma A/S | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 180753000 |
| Thursday, January 1, 2015 | 40528000 | 224193000 |
| Friday, January 1, 2016 | 66022000 | 197617000 |
| Sunday, January 1, 2017 | 99589000 | 288320000 |
| Monday, January 1, 2018 | 140281000 | 240661000 |
| Tuesday, January 1, 2019 | 191621000 | 276018000 |
| Wednesday, January 1, 2020 | 260904000 | 294216000 |
| Friday, January 1, 2021 | 295867000 | 354881000 |
| Saturday, January 1, 2022 | 379624000 | 361140000 |
| Sunday, January 1, 2023 | 413454000 | 330551000 |
| Monday, January 1, 2024 | 307004000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, research and development (R&D) investments are crucial for innovation and growth. Ascendis Pharma A/S and Grifols, S.A. have been at the forefront of this race, with their R&D expenses reflecting their commitment to advancing medical science. Over the past decade, Ascendis Pharma has shown a remarkable increase in R&D spending, growing by over 2,000% from 2014 to 2023. In contrast, Grifols, S.A. has maintained a steady investment, with a 83% increase over the same period. This trend highlights Ascendis Pharma's aggressive strategy to innovate and capture market share, while Grifols focuses on consistent, sustainable growth. As the industry evolves, these investments will likely play a pivotal role in shaping the future of healthcare solutions.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Grifols, S.A.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Bio-Techne Corporation and Grifols, S.A. Allocate Funds
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
R&D Spending Showdown: Grifols, S.A. vs Veracyte, Inc.
Grifols, S.A. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds